This article outlines how formulation changes and medication transitions may be requested when using compounded medications through our platform. All changes are subject to review and approval by a licensed provider and may vary based on your medical profile.
Switching Compounded Tirzepatide or Semaglutide Formulations: B12 to Glycine
If you are currently prescribed a compounded Semaglutide or Tirzepatide formulation with Vitamin B12 and prefer an alternative formulation, you may request a different option, such as Glycine.
Here’s how this works:
For an Active Order: Once an order has been filled by the pharmacy, changes cannot be made to that order. However, you can request a Glycine formulation for future shipments. Be sure to notify the care team after submitting your request so that they can update your medication plan for subsequent refills.
Switching Process for Future Orders: Submit a new treatment form and select Glycine as the preferred additive. Notify the care team to pause your current plan and ensure that future orders reflect your chosen formulation (Glycine).
Transitioning from Compounded Semaglutide to Tirzepatide
If you’re interested in transitioning from compounded Semaglutide to Tirzepatide, the process involves a new clinical review.
Here’s how this works:
Cancel Active Orders: Be sure to cancel any active orders before proceeding.
Complete a New Intake Form: You’ll need to fill out an updated intake form for the treatment.
Provider Review: A licensed provider will evaluate your request and determine whether Tirzepatide is appropriate for you.
Plan Coordination: If approved, your care team can assist with timing to help align with your current treatment schedule.
Key Notes
Immediate Changes to Active Orders: Currently, active orders that have already been processed by the pharmacy cannot be altered. It is always better to plan formulation changes ahead of your next shipment.
For further assistance, do not hesitate to message us!